DK0517986T3 - Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater - Google Patents

Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater

Info

Publication number
DK0517986T3
DK0517986T3 DK91401602.7T DK91401602T DK0517986T3 DK 0517986 T3 DK0517986 T3 DK 0517986T3 DK 91401602 T DK91401602 T DK 91401602T DK 0517986 T3 DK0517986 T3 DK 0517986T3
Authority
DK
Denmark
Prior art keywords
preparing
processes
same
pharmaceutical compositions
erythrocytes
Prior art date
Application number
DK91401602.7T
Other languages
Danish (da)
English (en)
Inventor
Mauro Magnani
Luigia Rossi
Original Assignee
Europ Communities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europ Communities filed Critical Europ Communities
Application granted granted Critical
Publication of DK0517986T3 publication Critical patent/DK0517986T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91401602.7T 1991-06-14 1991-06-14 Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater DK0517986T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401602A EP0517986B1 (de) 1991-06-14 1991-06-14 Transformierte Erythrozyten, Verfahren zu deren Herstellung, und ihre Verwendung in pharmazeutischen Zusammensetzungen

Publications (1)

Publication Number Publication Date
DK0517986T3 true DK0517986T3 (da) 1998-03-30

Family

ID=8208584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91401602.7T DK0517986T3 (da) 1991-06-14 1991-06-14 Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater

Country Status (10)

Country Link
US (1) US5753221A (de)
EP (1) EP0517986B1 (de)
JP (1) JPH06510742A (de)
AT (1) ATE157879T1 (de)
CA (1) CA2102619A1 (de)
DE (1) DE69127615T2 (de)
DK (1) DK0517986T3 (de)
ES (1) ES2109260T3 (de)
GR (1) GR3025488T3 (de)
WO (1) WO1992022306A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409710A (en) * 1993-04-20 1995-04-25 Endocon, Inc. Foam cell drug delivery
NZ290127A (en) * 1994-07-15 1998-05-27 Lepetit Spa Dinucleoside-5',5'-p1,p2-pyrophosphates; medicaments for treating tumours and viral infections
EP0882448B1 (de) * 1997-05-05 2005-01-12 DIDECO S.r.l. Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
ES2257050T3 (es) 1998-05-26 2006-07-16 Lifecell Corporation Conservacion por el frio de hematies humanos.
US20100040546A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US20100042072A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US20120034157A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20110213193A1 (en) * 2008-08-28 2011-09-01 The Florida International University Board Of Trustees Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier
BR112016011195A2 (pt) 2013-11-18 2017-09-19 Rubius Therapeutics Inc Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
KR20220150986A (ko) 2014-04-01 2022-11-11 루비우스 테라퓨틱스, 아이엔씨. 면역조절을 위한 방법 및 조성물
CA3084674A1 (en) 2017-12-23 2019-06-27 Rubius Therapeutics, Inc. Artificial antigen presenting cells and methods of use
WO2019173798A1 (en) 2018-03-08 2019-09-12 Rubius Therapeutics, Inc. Therapeutic cell systems and methods for treating cancer and infectious diseases
JP2022530130A (ja) 2019-04-26 2022-06-27 ルビウス セラピューティクス， インコーポレイテッド 除核赤血球細胞を含む緩衝組成物
JP2022533252A (ja) 2019-05-24 2022-07-21 ルビウス セラピューティクス， インコーポレイテッド 脱核赤血球細胞を生成する方法
CN115038784A (zh) 2019-11-04 2022-09-09 鲁比厄斯治疗法股份有限公司 使用肌-肌醇产生去核红系细胞的方法
EP4055148A1 (de) 2019-11-04 2022-09-14 Rubius Therapeutics, Inc. Verfahren zum erzeugen von enukelierten erythroidenzellen unter verwendung von taurin oder hypotaurin
WO2022150569A1 (en) 2021-01-08 2022-07-14 Rubius Therapeutics, Inc. METHODS OF INCREASING NKp30-POSITIVE LYMPHOCYTES IN A SUBJECT AND USES THEREOF
TW202241470A (zh) 2021-01-08 2022-11-01 美商盧比亞斯治療公司 治療人類個體腫瘤之方法
TW202304482A (zh) 2021-03-14 2023-02-01 美商盧比亞斯治療公司 於個體中增加nkg2d陽性淋巴球之方法及其用途
TW202317179A (zh) 2021-06-03 2023-05-01 美商盧比亞斯治療公司 在個體中治療ｈｐｖ１６－陽性或ｈｐｖ１６－相關的癌症之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
FR2653561A1 (fr) * 1989-10-19 1991-04-26 Fondation Nale Transfusion San Hetero-anticorps anti-rhd et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
US5753221A (en) 1998-05-19
DE69127615T2 (de) 1998-03-19
EP0517986A1 (de) 1992-12-16
ES2109260T3 (es) 1998-01-16
ATE157879T1 (de) 1997-09-15
WO1992022306A1 (en) 1992-12-23
JPH06510742A (ja) 1994-12-01
DE69127615D1 (de) 1997-10-16
GR3025488T3 (en) 1998-02-27
CA2102619A1 (en) 1992-12-15
EP0517986B1 (de) 1997-09-10

Similar Documents

Publication Publication Date Title
DK0517986T3 (da) Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
DK0791571T3 (da) Benzoylderivater
DK1200418T3 (da) Nematodicide trifluorbutener
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
BR0012970A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese
DK0516588T3 (da) Substituerede diaminophthalimider og analoger
TR200101649T2 (tr) Piperazin türevleri.
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
DK161642C (da) Phenoxy- eller phenylthioalkanderivater, skadedyrsbekaempende praeparat indeholdende saadanne derivater samt fremgangsmaade til bekaempelse af insekter og acari
DK462687A (da) Forbindelse til behandling af retrovirusinfektioner.
NO20010940D0 (no) TAN-1057 derivater
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DK418986D0 (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
DK47688A (da) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiaziner, deres fremstilling og anvendelse som laegemiddel
DK190983A (da) 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
BR0212719A (pt) Composto, método para produzir um composto, composição farmacêutica que compreende o mesmo, método para tratar uma enfermidade relacionada com os ossos em um paciente e sua utilização
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
TH9666EX (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค
DK0580624T3 (da) Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf